Author/Authors :
فاضلي، يوسف نويسنده Agricultural, Medical and Industrial Research School, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Karaj, I Fazaeli, Yousef , جليليان، امير رضا نويسنده Radiopharmaceutical Research and Development Lab, Nuclear Science and Technology Research Institute, Atomic Energy Organization of Iran, Tehran, Iran Jalilian, Amir R , محمدرضا رحيمي نژاد، علي اصغر معصومي نويسنده , , بلوري نوين، فاطمه نويسنده سازمان انرژي اتمي ايران,پژوهشگاه علوم و فنون هسته اي ,
Abstract :
labeling imaging agent using single photon emission computed chromatography (SPECT) with [111In]-maltolate complex has
been investigated.
Methods: [111In] labeled 3-hydroxy-2-methyl-4H-pyran-4-onate ([111In]-maltolate) was prepared using freshly prepared
[111In]InCl3 and 3-hydroxy-2-methyl-4H-pyran-4-onate in a sodium salt form in 25 min at 45?C. Stability of the complex
was checked in final formulation and human serum for 48 h. The partition coefficient was calculated for the compound
followed by biodistribution and imaging studies. [111In]-maltolate was successively used in the radiolabeling of red blood
cells for diagnostic studies.
Results: The complex was prepared successfully (radiochemical purity: > 98% ITLC, > 98% HPLC, specific activity: 15-17
GBq/mmol, log P=0.278). The complex is mostly washed out from the circulation through kidneys in 24h. the cell labeling
efficacy was significant at the time of experiment.
Conclusion: [111In]-maltolate can be an interesting cell imaging agent due to stability and cell avidity of metal maltol
complexes, however, further biodistribution studies in various cells as well as diagnostic protocols is necessary